Utilizing Peptide Ligand GPCRs to Image and Treat Pancreatic Cancer
It is estimated that early detection of pancreatic ductal adenocarcinoma (PDAC) could increase long-term patient survival by as much as 30% to 40% (Seufferlein, T. et al., Nat. Rev. Gastroenterol. Hepatol. 2016, 13, 74–75). There is an unmet need for reagents that can reliably identify ear...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-06-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | http://www.mdpi.com/2227-9059/6/2/65 |